Riverview Trust Company’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $40.4K | Buy |
516
+159
| +45% | +$12.4K | 0.05% | 136 |
|
2025
Q1 | $25.9K | Sell |
357
-10
| -3% | -$725 | 0.03% | 341 |
|
2024
Q4 | $27.2K | Sell |
367
-8
| -2% | -$592 | 0.02% | 347 |
|
2024
Q3 | $24.7K | Buy |
375
+18
| +5% | +$1.19K | 0.02% | 382 |
|
2024
Q2 | $33K | Hold |
357
| – | – | 0.03% | 291 |
|
2024
Q1 | $34.1K | Buy |
+357
| New | +$34.1K | 0.03% | 305 |
|
2023
Q3 | – | Sell |
-163
| Closed | -$15.4K | – | 690 |
|
2023
Q2 | $15.4K | Buy |
+163
| New | +$15.4K | 0.01% | 503 |
|
2022
Q3 | – | Sell |
-279
| Closed | -$27K | – | 765 |
|
2022
Q2 | $27K | Sell |
279
-248
| -47% | -$24K | 0.02% | 308 |
|
2022
Q1 | $62K | Buy |
+527
| New | +$62K | 0.05% | 193 |
|